Kelly Leanne M.

Director at WINDTREE THERAPEUTICS INC /DE/ · on record since Jan 14, 2025
SVP & Chief Financial Officer at GENAERA CORP · on record since Aug 13, 2008
Chief Financial Officer at GRI Bio, Inc. · on record since May 18, 2021

Insider trading activity of Kelly Leanne M.

Transactions on record: 15; since May 2, 2007

Open-market buys: 3; $25.2K

Open-market sells: 0

Companies traded: 2; last filing Sep 22, 2025

Figures computed from official regulatory filings — .

Companies where Kelly Leanne M. has traded

GRI Bio, Inc.9 tx · $463.2K · Sep 22, 2025
GENAERA CORP6 tx · Aug 13, 2008

Track record of Kelly Leanne M.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Kelly Leanne M.

Co-insiders of Kelly Leanne M.

Agro AlbertGRI Bio, Inc.
Amick W ThomasWINDTREE THERAPEUTICS INC /DE/
Ammer RichardGRI Bio, Inc.
Arcturus Therapeutics Holdings Inc.GRI Bio, Inc.
ARMSTRONG JOHN L JRGENAERA CORP
Baker David CharlesGRI Bio, Inc.
Bioengine Capital Inc.WINDTREE THERAPEUTICS INC /DE/
BIOTECHNOLOGY VALUE FUND II LPGENAERA CORP
BIOTECHNOLOGY VALUE FUND L PGENAERA CORP
BVF INC/ILGENAERA CORP
BVF INVESTMENTS LLCGENAERA CORP
BVF PARTNERS L P/ILGENAERA CORP
CAPETOLA ROBERT JWINDTREE THERAPEUTICS INC /DE/
CARMAN DIANEWINDTREE THERAPEUTICS INC /DE/
Center Laboratories, Inc.WINDTREE THERAPEUTICS INC /DE/
Chaturvedi VipinGRI Bio, Inc.
Chhabra MeenuGRI Bio, Inc.
China Cardiovascular Focus LtdWINDTREE THERAPEUTICS INC /DE/
Clayton RussellWINDTREE THERAPEUTICS INC /DE/
Cole KathyWINDTREE THERAPEUTICS INC /DE/
COOPER JOHN GWINDTREE THERAPEUTICS INC /DE/
Curtis EricWINDTREE THERAPEUTICS INC /DE/

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
GRI Bio, Inc.Listing on record	Sep 22, 2025	AwardD (derivative)	43,222	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GRI Bio, Inc.Listing on record	Aug 27, 2025	AwardD (derivative)	11,854	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GRI Bio, Inc.Listing on record	Jan 24, 2025	AwardD (derivative)	43,319	0.69 USD	$29.9K		SEC
GRI Bio, Inc.Listing on record	Sep 26, 2023	AwardD (derivative)	83,333	1.52 USD	$126.7K		SEC
GRI Bio, Inc.Listing on record	Mar 1, 2022	AwardD (derivative)	50,000	5.63 USD	$281.5K		SEC
GRI Bio, Inc.Listing on record	Jun 4, 2021	Buy	1,085	4.05 USD	$4.4K	conv 41	SEC
GRI Bio, Inc.Listing on record	Jun 4, 2021	Buy	1,508	4.08 USD	$6.2K	conv 42	SEC
GRI Bio, Inc.Listing on record	Jun 4, 2021	Buy	3,657	4.00 USD	$14.6K	conv 59First in 12mo	SEC
GRI Bio, Inc.Listing on record	May 18, 2021	AwardD (derivative)	70,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	Aug 13, 2008	AwardD (derivative)	300,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	Dec 18, 2007	ExerciseD (derivative)	-417	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	Dec 18, 2007	Exercise	417	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	Sep 28, 2007	AwardD (derivative)	275,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	May 22, 2007	AwardD (derivative)	100,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	May 2, 2007	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
GRI Bio, Inc.Listing on record	Sep 22, 2025	AwardD (derivative)	43,222	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GRI Bio, Inc.Listing on record	Aug 27, 2025	AwardD (derivative)	11,854	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GRI Bio, Inc.Listing on record	Jan 24, 2025	AwardD (derivative)	43,319	0.69 USD	$29.9K		SEC
GRI Bio, Inc.Listing on record	Sep 26, 2023	AwardD (derivative)	83,333	1.52 USD	$126.7K		SEC
GRI Bio, Inc.Listing on record	Mar 1, 2022	AwardD (derivative)	50,000	5.63 USD	$281.5K		SEC
GRI Bio, Inc.Listing on record	Jun 4, 2021	Buy	1,085	4.05 USD	$4.4K	conv 41	SEC
GRI Bio, Inc.Listing on record	Jun 4, 2021	Buy	1,508	4.08 USD	$6.2K	conv 42	SEC
GRI Bio, Inc.Listing on record	Jun 4, 2021	Buy	3,657	4.00 USD	$14.6K	conv 59First in 12mo	SEC
GRI Bio, Inc.Listing on record	May 18, 2021	AwardD (derivative)	70,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	Aug 13, 2008	AwardD (derivative)	300,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	Dec 18, 2007	ExerciseD (derivative)	-417	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	Dec 18, 2007	Exercise	417	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	Sep 28, 2007	AwardD (derivative)	275,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	May 22, 2007	AwardD (derivative)	100,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENAERA CORPListing unverified	May 2, 2007	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC